STAT3 and cancer: Sugiol, even if a minor compound only, also has significant pharmacological potential, reviewed recently by Bajpai et al. 2020 [83], that can, for example, attenuate STAT3-dependent proliferation and unlocks apoptosis pathways in cancer cells and can block virus entry to cells.